Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	57
Overall Study	STARTED	Arasertaconazole Nitrate 150 mg	58
Overall Study	STARTED	Arasertaconazole Nitrate 300 mg	58
Overall Study	STARTED	Arasertaconazole 600 mg	56
Overall Study	COMPLETED	Placebo	57
Overall Study	COMPLETED	Arasertaconazole Nitrate 150 mg	58
Overall Study	COMPLETED	Arasertaconazole Nitrate 300 mg	58
Overall Study	COMPLETED	Arasertaconazole 600 mg	56
Overall Study	NOT COMPLETED	Placebo	0
Overall Study	NOT COMPLETED	Arasertaconazole Nitrate 150 mg	0
Overall Study	NOT COMPLETED	Arasertaconazole Nitrate 300 mg	0
Overall Study	NOT COMPLETED	Arasertaconazole 600 mg	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01144286/flow